Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

OLON at DCAT 2019


March 18-21, 2019 - NY USA  – Meet OLON team at DCAT week

Olon SpA acquires CapuaBioservices SpA

January 25, 2019
Olon SpA acquires CapuaBioservices SpA
READ MORE
Olon Acquires Manufacturing Facility in India

4 September 2018
Olon announced the acquisition of a local manufacturing facility in Mahad, India.
READ MORE

OLON
Institutional Video


November 2018

Discover more about Olon

READ MORE

Olon on Pharma’s Almanac Magazine


May 2018

Strengthening the outsource service offering through integration...Click the image to read the full article

OLON acquired RICERCA


June 9th, 2017

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA). Acquisition strengthens service offering of global CDMO and Generics provider...

READ MORE
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Carbonylation

Olon with its new equipment and safety device can handle Carbon Monoxide (CO) at high pressure in both R&D Lab and production plant.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.